On June 8th, Complife Italia obtained from the Ministry of Health – General Directorate of Medical Devices and Pharmaceutical Service – the authorization to control Presidi Medico Chirurgici restricted to only controls: chemical controls, chemical-physical controls, microbiological controls.

The authorization, achieved by a limited number of laboratories on the national territory, represents an important step in the perspective of business growth, especially in a sector that has recently had a significant impact on our daily lives. This recognition completes the package of services in the Presidi Medico Chirurgici/biocides sector – validation of analytical methods, stability studies and efficacy evaluation – already offered by Complife Italia as a Good Laboratory Practice Test Facility.

“MORE INFORMATIONS”mailto%3Ainfo%40complifegroup.com